Document is current
Any future updates will be listed below
-
Authors
Pol-Fuster, Josep https://orcid.org/0000-0002-7066-3649
Fernández de la Cruz, Lorena https://orcid.org/0000-0002-1571-5485
Kuja-Halkola, Ralf https://orcid.org/0000-0002-3765-2067
de Schipper, Elles
Lichtenstein, Paul https://orcid.org/0000-0003-3037-5287
Chang, Zheng
Brikell, Isabell
M. D’Onofrio, Brian
Larsson, Henrik https://orcid.org/0000-0002-6851-3297
Rück, Christian
Brander, Gustaf
Beucke, Jan C.
Valdimarsdóttir, Unnur A.
Mataix-Cols, David https://orcid.org/0000-0002-4545-0924
- License Information
-
More Information
Article History
Received: 1 October 2025
Accepted: 16 March 2026
First Online: 9 April 2026
Competing interests
: L.F.d.l.C. receives royalties for contributing articles to UpToDate, Wolters Kluwer Health and fees for editorial work from Elsevier, all outside the submitted work. Z.C. received speaker fees from Takeda Pharmaceuticals, outside the submitted work. H.L. reports receiving grants from Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB; all outside the submitted work. H.L. is editor-in-chief of JCPP Advances. D.M.-C. receives royalties for contributing articles to UpToDate, Inc, and is part-owner of Scandinavian E-Health AB, all outside the submitted work. C.R. receives royalties for books or book chapters to Natur och Kultur, Studentlitteratur and Albert Bonniers Förlag and various speakers fees, all outside the submitted work. All other authors report no biomedical financial interests or potential conflicts of interest.
